koate-dvi for injection 1000 iu10 ml
grifols asia pacific pte. ltd. - antihemophilic factor (human) (factor viii) - injection, powder, for solution - min 800 iu/10 ml - antihemophilic factor (human) (factor viii) min 800 iu/10 ml
koate-dvi for injection 250 iu5 ml
grifols asia pacific pte. ltd. - antihemophilic factor (human) (factor viii) - injection, powder, for solution - min 250 iu/5 ml - antihemophilic factor (human) (factor viii) min 250 iu/5 ml
koate-dvi for injection 500 iu5 ml
grifols asia pacific pte. ltd. - antihemophilic factor (human) (factor viii) - injection, powder, for solution - min 400 iu/5 ml - antihemophilic factor (human) (factor viii) min 400 iu/5 ml
adequan canine polysulfated glycosaminoglycan injection solution
elanco us inc. - polysulfated glycosaminoglycan (unii: 268aw7000t) (polysulfated glycosaminoglycan - unii:268aw7000t) - polysulfated glycosaminoglycan 100 mg in 1 ml
adequan i.a.- polysulfated glycosaminoglycan injection, solution
american regent, inc. - polysulfated glycosaminoglycan (unii: 268aw7000t) (polysulfated glycosaminoglycan - unii:268aw7000t) - polysulfated glycosaminoglycan 250 mg in 1 ml - adequan is recommended for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal joint in horses. do not use in horses showing hypersensitivity to polysulfated glycosaminoglycan. do not administer adequan in the face of joint sepsis.
pms-iron sucrose solution
pharmascience inc - iron (iron sucrose) - solution - 20mg - iron (iron sucrose) 20mg - iron preparations
dexiron solution
american regent, inc - iron (iron dextran complex) - solution - 50mg - iron (iron dextran complex) 50mg - iron preparations
fomepizole injection solution
x-gen pharmaceuticals - fomepizole (unii: 83lcm6l2by) (fomepizole - unii:83lcm6l2by) - fomepizole 1 g in 1 ml